Edgewise Therapeutics’ (EWTX) Outperform Rating Reaffirmed at Royal Bank of Canada
Edgewise Therapeutics (NASDAQ:EWTX – Get Free Report)‘s stock had its “outperform” rating reissued by investment analysts at Royal Bank of Canada in a research note issued to investors on Tuesday,Benzinga reports. They presently have a $56.00 price target on the stock. Royal Bank of Canada’s price target suggests a potential upside of 109.66% from the […]
Edgewise Therapeutics (NASDAQ:EWTX – Get Free Report)‘s stock had its “outperform” rating reissued by investment analysts at Royal Bank of Canada in a research note issued to investors on Tuesday,Benzinga reports. They presently have a $56.00 price target on the stock. Royal Bank of Canada’s price target suggests a potential upside of 109.66% from the […]
